SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Transgene Biotek informs about board meeting

03 Nov 2021 Evaluate

Transgene Biotek has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021, to consider and approve the unaudited standalone & consolidated financial results for the quarter and half year ended on 30th September 2021; and to examine and take note of the Limited Review Report as provided by the Statutory Auditor of the Company.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.10 0.22 (7.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×